HEADER TRANSFERASE 31-MAY-18 6GNV TITLE CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE (NMT) TITLE 2 WITH BOUND MYRISTOYL-COA AND A ISOPROPYL METHYL INDOLE ARYL TITLE 3 SULPHONAMIDE LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.3.1.97; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEISHMANIA MAJOR; SOURCE 3 ORGANISM_TAXID: 5664; SOURCE 4 GENE: NMT, LMJF_32_0080; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ACYLTRANSFERASE, TRANSFERASE, DRUG DISCOVERY EXPDTA X-RAY DIFFRACTION AUTHOR D.A.ROBINSON,J.R.HARRISON,S.BRAND,V.C.SMITH,S.THOMPSON,A.SMITH, AUTHOR 2 K.DAVIES,N.Y.MOK,L.S.TORRIE,I.COLLIE,I.HALLYBURTON,S.NORVAL, AUTHOR 3 F.R.C.SIMEONS,L.STOJANOVSKI,J.A.FREARSON,R.BRENK,P.G.WYATT, AUTHOR 4 I.H.GILBERT,K.D.READ REVDAT 2 17-JAN-24 6GNV 1 COMPND REVDAT 1 10-OCT-18 6GNV 0 JRNL AUTH J.R.HARRISON,S.BRAND,V.SMITH,D.A.ROBINSON,S.THOMPSON, JRNL AUTH 2 A.SMITH,K.DAVIES,N.MOK,L.S.TORRIE,I.COLLIE,I.HALLYBURTON, JRNL AUTH 3 S.NORVAL,F.R.C.SIMEONS,L.STOJANOVSKI,J.A.FREARSON,R.BRENK, JRNL AUTH 4 P.G.WYATT,I.H.GILBERT,K.D.READ JRNL TITL A MOLECULAR HYBRIDIZATION APPROACH FOR THE DESIGN OF POTENT, JRNL TITL 2 HIGHLY SELECTIVE, AND BRAIN-PENETRANT N-MYRISTOYLTRANSFERASE JRNL TITL 3 INHIBITORS. JRNL REF J. MED. CHEM. V. 61 8374 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30207721 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00884 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 19781 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.152 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1548 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1469 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.37 REMARK 3 BIN R VALUE (WORKING SET) : 0.1990 REMARK 3 BIN FREE R VALUE SET COUNT : 104 REMARK 3 BIN FREE R VALUE : 0.2470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3331 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18000 REMARK 3 B22 (A**2) : 0.02000 REMARK 3 B33 (A**2) : 0.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.291 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.202 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.141 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.583 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3544 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3307 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4836 ; 1.892 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7608 ; 1.022 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 412 ; 6.841 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 169 ;37.925 ;23.669 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 548 ;17.243 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;20.906 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 509 ; 0.108 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3954 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 839 ; 0.007 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6GNV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010305. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0-6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21349 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 48.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.39400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3H5Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% PEG1500, 0.2M NACL, 0.1M REMARK 280 NACACODYLATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.21000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 268 NZ REMARK 470 LYS A 317 CD CE NZ REMARK 470 LYS A 412 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB SER A 298 O HOH A 606 1.87 REMARK 500 CD2 HIS A 398 O HOH A 603 2.04 REMARK 500 O HOH A 605 O HOH A 677 2.08 REMARK 500 CB MET A 87 O HOH A 803 2.10 REMARK 500 CB SER A 324 O HOH A 734 2.16 REMARK 500 O SER A 86 O HOH A 601 2.17 REMARK 500 CB CYS A 102 O HOH A 807 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 89 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG A 89 NE - CZ - NH2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ARG A 400 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 53 138.64 -35.82 REMARK 500 TYR A 80 -159.06 -84.22 REMARK 500 ALA A 118 -89.94 -54.23 REMARK 500 MET A 135 31.23 -150.22 REMARK 500 ASN A 196 31.10 72.59 REMARK 500 ILE A 230 -79.84 -91.22 REMARK 500 ARG A 231 1.97 -69.53 REMARK 500 ALA A 237 -78.81 -32.26 REMARK 500 ALA A 241 -44.41 -155.71 REMARK 500 ALA A 243 -48.95 140.91 REMARK 500 MET A 246 -58.91 67.96 REMARK 500 ASN A 337 -79.82 -47.91 REMARK 500 HIS A 347 -139.18 -105.32 REMARK 500 GLU A 379 46.56 -79.76 REMARK 500 LEU A 381 -136.30 45.95 REMARK 500 LYS A 391 41.28 72.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5E A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 503 DBREF 6GNV A 11 421 UNP Q4Q5S8 Q4Q5S8_LEIMA 11 421 SEQADV 6GNV ALA A 233 UNP Q4Q5S8 SER 233 CONFLICT SEQADV 6GNV ALA A 235 UNP Q4Q5S8 ILE 235 CONFLICT SEQADV 6GNV ALA A 240 UNP Q4Q5S8 GLN 240 CONFLICT SEQADV 6GNV ALA A 241 UNP Q4Q5S8 LYS 241 CONFLICT SEQADV 6GNV ALA A 243 UNP Q4Q5S8 GLN 243 CONFLICT SEQADV 6GNV ALA A 336 UNP Q4Q5S8 SER 336 CONFLICT SEQRES 1 A 411 ALA HIS ALA PHE TRP SER THR GLN PRO VAL PRO GLN THR SEQRES 2 A 411 GLU ASP GLU THR GLU LYS ILE VAL PHE ALA GLY PRO MET SEQRES 3 A 411 ASP GLU PRO LYS THR VAL ALA ASP ILE PRO GLU GLU PRO SEQRES 4 A 411 TYR PRO ILE ALA SER THR PHE GLU TRP TRP THR PRO ASN SEQRES 5 A 411 MET GLU ALA ALA ASP ASP ILE HIS ALA ILE TYR GLU LEU SEQRES 6 A 411 LEU ARG ASP ASN TYR VAL GLU ASP ASP ASP SER MET PHE SEQRES 7 A 411 ARG PHE ASN TYR SER GLU GLU PHE LEU GLN TRP ALA LEU SEQRES 8 A 411 CYS PRO PRO ASN TYR ILE PRO ASP TRP HIS VAL ALA VAL SEQRES 9 A 411 ARG ARG LYS ALA ASP LYS LYS LEU LEU ALA PHE ILE ALA SEQRES 10 A 411 GLY VAL PRO VAL THR LEU ARG MET GLY THR PRO LYS TYR SEQRES 11 A 411 MET LYS VAL LYS ALA GLN GLU LYS GLY GLU GLY GLU GLU SEQRES 12 A 411 ALA ALA LYS TYR ASP GLU PRO ARG HIS ILE CYS GLU ILE SEQRES 13 A 411 ASN PHE LEU CYS VAL HIS LYS GLN LEU ARG GLU LYS ARG SEQRES 14 A 411 LEU ALA PRO ILE LEU ILE LYS GLU ALA THR ARG ARG VAL SEQRES 15 A 411 ASN ARG THR ASN VAL TRP GLN ALA VAL TYR THR ALA GLY SEQRES 16 A 411 VAL LEU LEU PRO THR PRO TYR ALA SER GLY GLN TYR PHE SEQRES 17 A 411 HIS ARG SER LEU ASN PRO GLU LYS LEU VAL GLU ILE ARG SEQRES 18 A 411 PHE ALA GLY ALA PRO ALA GLN TYR ALA ALA PHE ALA ASN SEQRES 19 A 411 PRO MET ALA MET LEU LYS ARG ASN TYR GLN LEU PRO SER SEQRES 20 A 411 ALA PRO LYS ASN SER GLY LEU ARG GLU MET LYS PRO SER SEQRES 21 A 411 ASP VAL PRO GLN VAL ARG ARG ILE LEU MET ASN TYR LEU SEQRES 22 A 411 ASP SER PHE ASP VAL GLY PRO VAL PHE SER ASP ALA GLU SEQRES 23 A 411 ILE SER HIS TYR LEU LEU PRO ARG ASP GLY VAL VAL PHE SEQRES 24 A 411 THR TYR VAL VAL GLU ASN ASP LYS LYS VAL THR ASP PHE SEQRES 25 A 411 PHE SER PHE TYR ARG ILE PRO SER THR VAL ILE GLY ASN SEQRES 26 A 411 ALA ASN TYR ASN LEU LEU ASN ALA ALA TYR VAL HIS TYR SEQRES 27 A 411 TYR ALA ALA THR SER ILE PRO LEU HIS GLN LEU ILE LEU SEQRES 28 A 411 ASP LEU LEU ILE VAL ALA HIS SER ARG GLY PHE ASP VAL SEQRES 29 A 411 CYS ASN MET VAL GLU ILE LEU ASP ASN ARG SER PHE VAL SEQRES 30 A 411 GLU GLN LEU LYS PHE GLY ALA GLY ASP GLY HIS LEU ARG SEQRES 31 A 411 TYR TYR PHE TYR ASN TRP ALA TYR PRO LYS ILE LYS PRO SEQRES 32 A 411 SER GLN VAL ALA LEU VAL MET LEU HET MYA A 501 63 HET F5E A 502 35 HET GOL A 503 6 HETNAM MYA TETRADECANOYL-COA HETNAM F5E ~{N}-[2-METHYL-5-(2-METHYLPROPYL)INDAZOL-4-YL]-4-[4-(1- HETNAM 2 F5E METHYLPIPERIDIN-4-YL)BUTYL]BENZENESULFONAMIDE HETNAM GOL GLYCEROL HETSYN MYA MYRISTOYL-COA HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 MYA C35 H62 N7 O17 P3 S FORMUL 3 F5E C28 H40 N4 O2 S FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *233(H2 O) HELIX 1 AA1 PHE A 14 GLN A 18 5 5 HELIX 2 AA2 THR A 23 LYS A 29 1 7 HELIX 3 AA3 ALA A 65 TYR A 80 1 16 HELIX 4 AA4 SER A 93 CYS A 102 1 10 HELIX 5 AA5 ILE A 107 ASP A 109 5 3 HELIX 6 AA6 PRO A 138 GLU A 147 1 10 HELIX 7 AA7 GLU A 150 ALA A 155 1 6 HELIX 8 AA8 LYS A 173 ARG A 176 5 4 HELIX 9 AA9 ARG A 179 THR A 195 1 17 HELIX 10 AB1 ASN A 223 PHE A 232 1 10 HELIX 11 AB2 GLN A 238 ALA A 243 1 6 HELIX 12 AB3 MET A 246 GLN A 254 1 9 HELIX 13 AB4 LYS A 268 SER A 270 5 3 HELIX 14 AB5 ASP A 271 ASP A 284 1 14 HELIX 15 AB6 SER A 293 LEU A 302 1 10 HELIX 16 AB7 PRO A 355 ARG A 370 1 16 HELIX 17 AB8 ASP A 382 SER A 385 5 4 HELIX 18 AB9 PHE A 386 LYS A 391 1 6 HELIX 19 AC1 LYS A 412 VAL A 416 5 5 SHEET 1 AA112 PHE A 56 TRP A 59 0 SHEET 2 AA112 HIS A 111 ARG A 116 -1 O ALA A 113 N TRP A 59 SHEET 3 AA112 LEU A 122 ARG A 134 -1 O LEU A 123 N VAL A 114 SHEET 4 AA112 ARG A 161 VAL A 171 -1 O ILE A 163 N VAL A 131 SHEET 5 AA112 ALA A 200 ALA A 204 1 O VAL A 201 N ILE A 166 SHEET 6 AA112 GLY A 393 TYR A 404 -1 O ARG A 400 N ALA A 204 SHEET 7 AA112 ALA A 213 SER A 221 -1 N GLY A 215 O LEU A 399 SHEET 8 AA112 VAL A 374 VAL A 378 -1 O MET A 377 N PHE A 218 SHEET 9 AA112 LEU A 340 ALA A 351 1 N ALA A 344 O ASN A 376 SHEET 10 AA112 LYS A 318 VAL A 332 -1 N SER A 330 O LEU A 341 SHEET 11 AA112 VAL A 308 ASN A 315 -1 N VAL A 313 O ASP A 321 SHEET 12 AA112 LEU A 264 GLU A 266 -1 N ARG A 265 O VAL A 312 SHEET 1 AA210 PHE A 88 PHE A 90 0 SHEET 2 AA210 LYS A 318 VAL A 332 -1 O THR A 331 N ARG A 89 SHEET 3 AA210 LEU A 340 ALA A 351 -1 O LEU A 341 N SER A 330 SHEET 4 AA210 VAL A 374 VAL A 378 1 O ASN A 376 N ALA A 344 SHEET 5 AA210 ALA A 213 SER A 221 -1 N PHE A 218 O MET A 377 SHEET 6 AA210 GLY A 393 TYR A 404 -1 O LEU A 399 N GLY A 215 SHEET 7 AA210 ALA A 200 ALA A 204 -1 N ALA A 204 O ARG A 400 SHEET 8 AA210 ARG A 161 VAL A 171 1 N ILE A 166 O VAL A 201 SHEET 9 AA210 LEU A 122 ARG A 134 -1 N VAL A 131 O ILE A 163 SHEET 10 AA210 GLY A 289 PRO A 290 -1 O GLY A 289 N ARG A 134 CISPEP 1 PRO A 209 THR A 210 0 -9.12 CISPEP 2 PHE A 232 ALA A 233 0 -13.21 SITE 1 AC1 33 HIS A 12 ALA A 13 PHE A 14 TRP A 15 SITE 2 AC1 33 ASN A 79 TYR A 80 VAL A 81 ILE A 166 SITE 3 AC1 33 PHE A 168 LEU A 169 CYS A 170 VAL A 171 SITE 4 AC1 33 ARG A 176 GLU A 177 LYS A 178 ARG A 179 SITE 5 AC1 33 LEU A 180 ALA A 181 PRO A 182 THR A 189 SITE 6 AC1 33 TRP A 198 ALA A 200 TYR A 202 THR A 203 SITE 7 AC1 33 LEU A 208 TYR A 404 HOH A 646 HOH A 656 SITE 8 AC1 33 HOH A 676 HOH A 679 HOH A 750 HOH A 771 SITE 9 AC1 33 HOH A 788 SITE 1 AC2 17 TYR A 80 VAL A 81 PHE A 88 PHE A 90 SITE 2 AC2 17 ASN A 167 THR A 203 TYR A 217 HIS A 219 SITE 3 AC2 17 SER A 330 LEU A 341 ASN A 376 GLY A 395 SITE 4 AC2 17 ASP A 396 GLY A 397 LEU A 421 HOH A 626 SITE 5 AC2 17 HOH A 638 SITE 1 AC3 10 VAL A 131 GLU A 165 PHE A 292 TYR A 348 SITE 2 AC3 10 LEU A 418 VAL A 419 LEU A 421 HOH A 602 SITE 3 AC3 10 HOH A 620 HOH A 640 CRYST1 48.700 90.420 53.680 90.00 114.83 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020534 0.000000 0.009501 0.00000 SCALE2 0.000000 0.011060 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020526 0.00000